In short
When FDA detains imported food, cosmetics, drugs or devices, you generally have about 10 business days to submit evidence, per the “respond by” date on the notice. If relabeling or reprocessing can fix the problem, you can apply to recondition. If the goods are finally refused, they must be exported within 90 days of the refusal notice or destroyed. FDA’s standard is that the goods “appear” violative, and the importer must overcome that appearance with evidence. Repeated problems can put a product on an import alert, after which shipments are detained automatically.
What FDA regulates at import
FDA decides admissibility for food (including dietary supplements and pet food), cosmetics, drugs, medical devices, radiation-emitting electronics and tobacco products. CBP enforces, but FDA decides whether the goods may enter, so FDA holds follow FDA’s procedures and deadlines, not CBP’s 30-day detention rule.
At entry, the broker transmits data to FDA as well. FDA screens for risk and may let the goods proceed, put them on hold for information or sampling, detain them with an opportunity to respond, or refuse them. The importer receives the corresponding Notice of FDA Action.
FDA’s standard: goods that “appear” violative
Under section 801(a) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. §381(a)), FDA may refuse admission if it “appears from the examination of such samples or otherwise” that goods are adulterated, misbranded or forbidden. That is far below a conviction standard. FDA need not prove a violation, only its appearance, and it can detain without examining the goods, based on documentary evidence such as prior violations by the same firm.
In practice the burden is on the importer to overcome the appearance with test reports, production records, registrations and label support.
The most common reasons for detention
1. Labeling
No English label, noncompliant ingredient or nutrition labeling, undeclared allergens, missing manufacturer or distributor information, or disease-treatment claims make a product misbranded. Many detentions are label problems, and many label problems can be reconditioned.
2. Registration, listing and Prior Notice
Food facilities must register with FDA; food imports need Prior Notice; drugs and devices need registration, listing and in some cases approval or clearance; cosmetic facilities and products have registration and listing requirements. Missing any of these can stop the goods.
3. Test results
FDA sampling finds pesticide residues, heavy metals, microbes, undeclared ingredients or prohibited substances, such as undeclared drug ingredients in supplements.
4. Importer obligations
Food importers must verify foreign suppliers under the Foreign Supplier Verification Program (FSVP) and identify the FSVP importer at entry. Lacking a program creates problems too.
5. Products on an import alert
FDA issues import alerts for repeat-violation products, firms or regions. Listed shipments are subject to detention without physical examination (DWPE) unless the importer proves the shipment complies.
Product-specific requirements
Cosmetics
Under the Modernization of Cosmetics Regulation Act of 2022, cosmetic manufacturing and processing facilities must register with FDA, marketed cosmetic products must be listed, and labels must include a domestic contact for adverse event reports. Products claiming whitening, spot removal, hair growth or sun protection may be drugs in the United States and must meet drug requirements, one of the most common traps for imported cosmetics.
Dietary supplements
Supplements use the “Supplement Facts” label. Structure/function claims such as “supports joint health” are allowed with FDA’s required disclaimer, but not claims to treat, cure or prevent disease. Products containing a new dietary ingredient, one not marketed in the U.S. before 1994, generally require a premarket notification to FDA. Undeclared drug ingredients are a top focus of detentions and import alerts.
Medical devices
Devices fall into three risk classes. Most Class II devices need 510(k) clearance before marketing and Class III devices need premarket approval; manufacturers must register and list their devices. Masks, thermometers, massagers and some beauty devices can be medical devices without importers realizing it.
Drugs
Over-the-counter drugs must conform to the applicable monograph or be approved; manufacturers must register, and drugs must be listed with a National Drug Code. Herbal or traditional medicines labeled with treatment claims are usually detained as unapproved new drugs.
When FDA and CBP procedures run at the same time
One shipment can be detained by FDA and also detained or examined by CBP, such as food with both a label problem and an origin question. Keep them separate: answer FDA on FDA’s deadline and CBP on CBP’s. What you submit to each must be consistent. If refused goods are exported, coordinate the export and timing with CBP. Goods seized by CBP are no longer handled through FDA’s export process.
After a detention notice: testimony and hearing
When goods appear subject to refusal, FDA issues a written Notice of FDA Action for detention and hearing, stating the reasons and giving the owner or consignee the opportunity to introduce testimony (21 C.F.R. §1.94). The notice shows a “respond by” date. FDA’s Regulatory Procedures Manual generally allows 10 business days from the date of detention; if you need more time, ask in writing before the deadline.
Testimony can be written or in person. Common evidence includes:
- Sampling and testing by a qualified private laboratory under accepted procedures, with a report showing the alleged problem is absent. For import-alert products this is often the main path to release.
- Production records, formulas, raw-material tests and specifications.
- FDA registration numbers, listings, approvals or clearances, and Prior Notice confirmations.
- Label proofs and explanations of each label element.
- FSVP documents and supplier verification records.
The key is to answer each charge on the notice and show why the goods actually comply.
Reconditioning: relabeling or reprocessing
If the problem can be corrected, such as by relabeling or sorting out the noncompliant portion, the importer can apply on Form FDA 766 to recondition under FDA supervision. The application states the method, location and timing. Once approved, the importer carries it out and notifies FDA for inspection; compliant goods are released and rejects are exported or destroyed. The importer pays the costs, including FDA supervision.
Reconditioning is often the fastest route for label problems, but if it is too expensive, export may make more sense.
Final refusal: export within 90 days or destruction
If the importer cannot overcome the appearance of a violation, FDA issues a notice of refusal. By statute, refused goods must be exported under CBP supervision within 90 days of the refusal notice, or they will be destroyed (21 U.S.C. §381(a)). Extensions are requested from CBP.
Two cautions. First, FDA may destroy refused drugs and devices valued at US$2,500 or less (or a higher amount set by Treasury) without an opportunity to export, after notice and an opportunity to present testimony. Second, if goods were conditionally released before FDA decided, CBP will demand redelivery, and failure to redeliver means liquidated damages under the bond, potentially up to the value of the goods (19 C.F.R. §141.113). Do not distribute FDA-regulated goods before final FDA release.
Import alerts: getting on and getting off
When FDA sees repeated violations by a product, firm or region, it issues an import alert and places them on a “red list.” Every later shipment is detained, and the importer must prove compliance each time, which is expensive.
Removal generally requires a petition showing that the cause was identified and corrected, with evidence such as a series of consecutive shipments tested compliant by a private laboratory, or other proof the problem is resolved. The specific requirements are set out in each import alert. It often takes months or longer, so the best course is to avoid getting listed.
An example
The following is a hypothetical example to illustrate the process, not a real case.
An importer brings in cookies from Taiwan and receives an FDA detention and hearing notice citing two problems: a nutrition label not in U.S. format and an undeclared tree-nut allergen. The respond-by date is 10 business days out.
After consulting counsel, the importer chooses reconditioning over export. On day three it files Form FDA 766 with a redesigned U.S.-format nutrition label and allergen statement, explaining that workers will apply the new labels package by package at a Los Angeles warehouse over five days. FDA approves; the importer finishes, notifies FDA for inspection, and the goods are released. The importer then has the factory use U.S. labels at the source.
The lessons: decide first whether the problem can be reconditioned; if so, propose a specific, workable plan quickly; and fix the root cause so the same problem does not lead to an import alert.
Preventing FDA detentions
- Confirm which FDA category the product falls in and what applies.
- Register facilities; complete listings and any required approvals or clearances.
- File Prior Notice for every food shipment; maintain an FSVP as a food importer.
- Have labels reviewed before shipping: English, ingredients, nutrition, allergens, net quantity, manufacturer or distributor, and no disease claims.
- Test high-risk products at a qualified lab before shipping and keep the reports.
- Do not distribute before final FDA release.
- Check whether the product or supplier is on an import alert.
Deadlines at a glance
- Response to detention: the notice’s respond-by date, generally 10 business days from detention, extendable on request (21 C.F.R. §1.94).
- Reconditioning: generally applied for on Form FDA 766 within the response period.
- Export after refusal: within 90 days of the refusal notice, or destruction (21 U.S.C. §381(a)).
- CBP redelivery demand: generally within 30 days after release or the end of conditional release; extended if FDA issues a sampling or detention notice within 30 days of release (19 C.F.R. §141.113).
When to call a lawyer
A missing registration or one label correction is usually work for your broker or a compliance consultant. Call a lawyer when tests show prohibited or undeclared substances; when a product is or may be placed on an import alert; when goods were already distributed and CBP demands redelivery; when drug or device approvals are at issue; when FDA’s finding clearly misstates the facts and formal testimony or a hearing is needed; or when CBP detentions or penalties are also involved.
Attorney Cynthia Wu handles import and customs matters personally, in English or Mandarin, is admitted to the U.S. Court of International Trade, and is a co-founder of a licensed customs brokerage, so she knows how FDA and CBP connect at entry. In 2025 we helped importers obtain the release of more than US$10 million in detained goods. Every case is different, and prior results do not guarantee a similar outcome. Consultations are by phone.
Frequently asked questions
How is an FDA detention different from a CBP detention?
FDA decides admissibility in an FDA detention, under FDA’s testimony, reconditioning and refusal procedures. CBP detentions follow CBP’s notice and 30-day rules. Deadlines and decision-makers differ, so respond to each separately.
Ten business days is not enough. What can I do?
Ask in writing before the respond-by date for an extension, explaining how much time you need and why, for example pending lab results.
Can I use my own lab?
Yes, if the lab is qualified and sampling and testing follow procedures FDA accepts, and the report speaks to this shipment. An old report from a different lot is usually not accepted.
Can refused goods be sold in another country?
Refused goods can be exported under CBP supervision to a destination the importer chooses, subject to that country’s rules. If not exported in time, they are destroyed.
Can I keep importing a product on an import alert?
Yes, but each shipment will be detained until you prove compliance. Petition for removal as early as you can.
Related: Air cargo holds at LAX · CBP Notice of Detention · CBP detentions, seizures and penalties guide
Sources: Federal Food, Drug, and Cosmetic Act §801(a) (21 U.S.C. §381(a)); Modernization of Cosmetics Regulation Act of 2022; 21 C.F.R. §1.94; 19 C.F.R. §141.113; FDA Regulatory Procedures Manual, chapter 9; FDA “Detention & Hearing” guidance page. Current as of November 2026.
Attorney advertising. General information, not legal advice. Prior results do not guarantee a similar outcome.
Part of the guide: CBP Detentions, Seizures and Penalties: A Guide for Importers

